A carregar...
Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer
We undertook an early phase II study of mixed 19‐peptide cancer vaccine monotherapy for 14 advanced metastatic triple‐negative breast cancer (mTNBC) patients refractory to systemic chemotherapy to develop a new type of cancer vaccine. The treatment protocol consisted of a weekly vaccination for 6 we...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7419019/ https://ncbi.nlm.nih.gov/pubmed/32495455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14510 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|